Urokinase-type plasminogen activator and its inhibitor type 1 predict disease outcome and therapy response in primary breast cancer

N Harbeck, RE Kates, M Schmitt, K Gauger, M Kiechle, F Jänicke, C Thomssen, Maxime Look, John Foekens

Research output: Contribution to journal › Article › Academic

90 Citations (Scopus)

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{6edd365d272240e18d670121518e3b9a,

title = "Urokinase-type plasminogen activator and its inhibitor type 1 predict disease outcome and therapy response in primary breast cancer",

author = "N Harbeck and RE Kates and M Schmitt and K Gauger and M Kiechle and F J{\"a}nicke and C Thomssen and Maxime Look and John Foekens",

year = "2004",

language = "Undefined/Unknown",

volume = "5",

pages = "348--352",

journal = "Clinical Breast Cancer",

issn = "1526-8209",

publisher = "Elsevier",

number = "5",

}

TY - JOUR

T1 - Urokinase-type plasminogen activator and its inhibitor type 1 predict disease outcome and therapy response in primary breast cancer

AU - Harbeck, N

AU - Kates, RE

AU - Schmitt, M

AU - Gauger, K

AU - Kiechle, M

AU - Jänicke, F

AU - Thomssen, C

AU - Look, Maxime

AU - Foekens, John

PY - 2004

Y1 - 2004

M3 - Article

SN - 1526-8209

VL - 5

SP - 348

EP - 352

JO - Clinical Breast Cancer

JF - Clinical Breast Cancer

IS - 5

ER -